_id
691b09b53c536f8df23189cc
Ticker
ALGEN.PA
Name
Genoway
Exchange
PA
Address
Technopark 2, Lyon, France, 69007
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.genoway.com
Description
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.
Last Close
2.65
Volume
3189
Current Price
2.6
Change
4.905660377358487
Last Updated
2025-12-30T12:36:59.009Z
Image
https://logo.clearbit.com/www.genoway.com
Ipo Date
2007-05-07T00:00:00.000Z
Market Cap
32056810
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
9603000
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
9468000
Operating Income
135000
Interest Expense
77000
Pretax Income
-
Net Income
143000
Eps
0.014520064647795525
Dividends Per Share
-
Shares Outstanding
12096908
Income Tax Expense
143000
EBITDA
382000
Operating Margin
1.4058106841611997
Total Other Income Expense Net
-135000
Cash
2129701
Short Term Investments
-
Receivables
7208000
Inventories
1395395
Total Current Assets
17100410
Property Plant Equipment
12600670
Total Assets
38823651
Payables
2175950
Short Term Debt
1437895
Long Term Debt
13051467
Total Liabilities
20433528
Equity
18390123
Bs_currency_symbol
EUR
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
2125181
Cf_currency_symbol
-
PE
14.7222
PB
1.392374950401365
ROE
0.7775913189922655
ROA
0.36833217978391575
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
48
Deep Value Investing Score
4.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
7
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
6
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
9603000
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
9468000
Quarters > 0 > income Statement > operating Income
135000
Quarters > 0 > income Statement > interest Expense
77000
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
143000
Quarters > 0 > income Statement > eps
0.014520064647795525
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
9848441
Quarters > 0 > income Statement > income Tax Expense
143000
Quarters > 0 > income Statement > EBITDA
382000
Quarters > 0 > income Statement > operating Margin
1.4058106841611997
Quarters > 0 > income Statement > total Other Income Expense Net
-135000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
2129701
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
7208000
Quarters > 0 > balance Sheet > inventories
1395395
Quarters > 0 > balance Sheet > total Current Assets
17100410
Quarters > 0 > balance Sheet > property Plant Equipment
12600670
Quarters > 0 > balance Sheet > total Assets
38823651
Quarters > 0 > balance Sheet > payables
2175950
Quarters > 0 > balance Sheet > short Term Debt
1437895
Quarters > 0 > balance Sheet > long Term Debt
13051467
Quarters > 0 > balance Sheet > total Liabilities
20433528
Quarters > 0 > balance Sheet > equity
18390123
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
2125181
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.014520064647795525
Quarters > 0 > ratios > PB
1.392374950401365
Quarters > 0 > ratios > ROE
0.7775913189922655
Quarters > 0 > ratios > ROA
0.36833217978391575
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
48
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
11348888
Quarters > 1 > income Statement > cost Of Revenue
6480874
Quarters > 1 > income Statement > gross Profit
7814416
Quarters > 1 > income Statement > operating Expenses
6699536
Quarters > 1 > income Statement > operating Income
-1214202
Quarters > 1 > income Statement > interest Expense
44421
Quarters > 1 > income Statement > pretax Income
-905330
Quarters > 1 > income Statement > net Income
1124692
Quarters > 1 > income Statement > eps
0.11420000383817093
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
9848441
Quarters > 1 > income Statement > income Tax Expense
2197775
Quarters > 1 > income Statement > EBITDA
442952
Quarters > 1 > income Statement > operating Margin
-10.698863183776243
Quarters > 1 > income Statement > total Other Income Expense Net
308872
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
4952511
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
7013818
Quarters > 1 > balance Sheet > inventories
1090226
Quarters > 1 > balance Sheet > total Current Assets
17454612
Quarters > 1 > balance Sheet > property Plant Equipment
5560688
Quarters > 1 > balance Sheet > total Assets
31800246
Quarters > 1 > balance Sheet > payables
2894154
Quarters > 1 > balance Sheet > short Term Debt
1437188
Quarters > 1 > balance Sheet > long Term Debt
4138299
Quarters > 1 > balance Sheet > total Liabilities
13225380
Quarters > 1 > balance Sheet > equity
18574866
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
1124692
Quarters > 1 > cash Flow > depreciation
1303862
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-4854461
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.11420000383817093
Quarters > 1 > ratios > PB
1.3785265853331055
Quarters > 1 > ratios > ROE
6.054913128310051
Quarters > 1 > ratios > ROA
3.5367399359111875
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
61
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
10710000
Quarters > 2 > income Statement > cost Of Revenue
6324167
Quarters > 2 > income Statement > gross Profit
6911964
Quarters > 2 > income Statement > operating Expenses
6214681
Quarters > 2 > income Statement > operating Income
-1265090
Quarters > 2 > income Statement > interest Expense
102092
Quarters > 2 > income Statement > pretax Income
-1057467
Quarters > 2 > income Statement > net Income
706000
Quarters > 2 > income Statement > eps
0.07609999798432017
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
9277267
Quarters > 2 > income Statement > income Tax Expense
-1763775
Quarters > 2 > income Statement > EBITDA
326671
Quarters > 2 > income Statement > operating Margin
-11.812231559290383
Quarters > 2 > income Statement > total Other Income Expense Net
207623
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
4861837
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
5416657
Quarters > 2 > balance Sheet > inventories
1030762
Quarters > 2 > balance Sheet > total Current Assets
17265782
Quarters > 2 > balance Sheet > property Plant Equipment
5958031
Quarters > 2 > balance Sheet > total Assets
31723156
Quarters > 2 > balance Sheet > payables
3556958
Quarters > 2 > balance Sheet > short Term Debt
1711671
Quarters > 2 > balance Sheet > long Term Debt
4663445
Quarters > 2 > balance Sheet > total Liabilities
13941426
Quarters > 2 > balance Sheet > equity
17781730
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
706308
Quarters > 2 > cash Flow > depreciation
1282047
Quarters > 2 > cash Flow > change In Working Capital
1294378
Quarters > 2 > cash Flow > cash From Operations
3250645
Quarters > 2 > cash Flow > capital Expenditures
542065
Quarters > 2 > cash Flow > cash From Investing
-1670195
Quarters > 2 > cash Flow > cash From Financing
-976617
Quarters > 2 > cash Flow > net Change In Cash
601403
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
0.07609999798432017
Quarters > 2 > ratios > PB
1.3564987321256143
Quarters > 2 > ratios > ROE
3.970367337711235
Quarters > 2 > ratios > ROA
2.2255036667852344
Quarters > 2 > ratios > FCF
2708580
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.2529019607843137
Quarters > 2 > health Score
71
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
10714396
Quarters > 3 > income Statement > cost Of Revenue
-8486358
Quarters > 3 > income Statement > gross Profit
19201136
Quarters > 3 > income Statement > operating Expenses
7774585
Quarters > 3 > income Statement > operating Income
-2508909
Quarters > 3 > income Statement > interest Expense
64839
Quarters > 3 > income Statement > pretax Income
-1292685
Quarters > 3 > income Statement > net Income
550112
Quarters > 3 > income Statement > eps
0.062230673815326785
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
8839885
Quarters > 3 > income Statement > income Tax Expense
-1842372
Quarters > 3 > income Statement > EBITDA
5711883
Quarters > 3 > income Statement > operating Margin
-23.416242968805708
Quarters > 3 > income Statement > total Other Income Expense Net
1216224
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
4260434
Quarters > 3 > balance Sheet > short Term Investments
523401
Quarters > 3 > balance Sheet > receivables
12255211
Quarters > 3 > balance Sheet > inventories
982751
Quarters > 3 > balance Sheet > total Current Assets
17729738
Quarters > 3 > balance Sheet > property Plant Equipment
5879089
Quarters > 3 > balance Sheet > total Assets
31842370
Quarters > 3 > balance Sheet > payables
2580872
Quarters > 3 > balance Sheet > short Term Debt
1714102
Quarters > 3 > balance Sheet > long Term Debt
5519301
Quarters > 3 > balance Sheet > total Liabilities
14459513
Quarters > 3 > balance Sheet > equity
17382857
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
549687
Quarters > 3 > cash Flow > depreciation
4286900
Quarters > 3 > cash Flow > change In Working Capital
-729860
Quarters > 3 > cash Flow > cash From Operations
3063460
Quarters > 3 > cash Flow > capital Expenditures
1783210
Quarters > 3 > cash Flow > cash From Investing
-1998540
Quarters > 3 > cash Flow > cash From Financing
-1686710
Quarters > 3 > cash Flow > net Change In Cash
-2808069
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
0.062230673815326785
Quarters > 3 > ratios > PB
1.3222050322337693
Quarters > 3 > ratios > ROE
3.164681156843205
Quarters > 3 > ratios > ROA
1.7276100993738843
Quarters > 3 > ratios > FCF
1280250
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.11948877006226016
Quarters > 3 > health Score
61
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
22059000
Annuals > 0 > income Statement > cost Of Revenue
12805041
Annuals > 0 > income Statement > gross Profit
-1885344
Annuals > 0 > income Statement > operating Expenses
12914217
Annuals > 0 > income Statement > operating Income
1812000
Annuals > 0 > income Statement > interest Expense
146513
Annuals > 0 > income Statement > pretax Income
-1962797
Annuals > 0 > income Statement > net Income
1831000
Annuals > 0 > income Statement > eps
0.1930999920482035
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
9482134
Annuals > 0 > income Statement > income Tax Expense
-3793531
Annuals > 0 > income Statement > EBITDA
3894009
Annuals > 0 > income Statement > operating Margin
8.214334285325716
Annuals > 0 > income Statement > total Other Income Expense Net
-4564
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
4952511
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
7013818
Annuals > 0 > balance Sheet > inventories
1090226
Annuals > 0 > balance Sheet > total Current Assets
17454612
Annuals > 0 > balance Sheet > property Plant Equipment
5560688
Annuals > 0 > balance Sheet > total Assets
31800246
Annuals > 0 > balance Sheet > payables
2894154
Annuals > 0 > balance Sheet > short Term Debt
1437188
Annuals > 0 > balance Sheet > long Term Debt
4138299
Annuals > 0 > balance Sheet > total Liabilities
13225380
Annuals > 0 > balance Sheet > equity
18574866
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
1830734
Annuals > 0 > cash Flow > depreciation
2969808
Annuals > 0 > cash Flow > change In Working Capital
1002809
Annuals > 0 > cash Flow > cash From Operations
5382069
Annuals > 0 > cash Flow > capital Expenditures
2387711
Annuals > 0 > cash Flow > cash From Investing
-2855933
Annuals > 0 > cash Flow > cash From Financing
-1828067
Annuals > 0 > cash Flow > net Change In Cash
698069
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.1930999920482035
Annuals > 0 > ratios > PB
1.3783012916486181
Annuals > 0 > ratios > ROE
9.857406239162101
Annuals > 0 > ratios > ROA
5.757817093616194
Annuals > 0 > ratios > FCF
2994358
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.13574314338818622
Annuals > 0 > health Score
72
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
20046382
Annuals > 1 > income Statement > cost Of Revenue
1242800
Annuals > 1 > income Statement > gross Profit
18803582
Annuals > 1 > income Statement > operating Expenses
16738286
Annuals > 1 > income Statement > operating Income
2065296
Annuals > 1 > income Statement > interest Expense
109069
Annuals > 1 > income Statement > pretax Income
1547573
Annuals > 1 > income Statement > net Income
1567575
Annuals > 1 > income Statement > eps
0.17367216120259807
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
9026058
Annuals > 1 > income Statement > income Tax Expense
-20000
Annuals > 1 > income Statement > EBITDA
6350750
Annuals > 1 > income Statement > operating Margin
10.302587269862462
Annuals > 1 > income Statement > total Other Income Expense Net
-517723
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
4260434
Annuals > 1 > balance Sheet > short Term Investments
523401
Annuals > 1 > balance Sheet > receivables
5595885
Annuals > 1 > balance Sheet > inventories
982751
Annuals > 1 > balance Sheet > total Current Assets
17729738
Annuals > 1 > balance Sheet > property Plant Equipment
5879089
Annuals > 1 > balance Sheet > total Assets
31842370
Annuals > 1 > balance Sheet > payables
2580872
Annuals > 1 > balance Sheet > short Term Debt
1714102
Annuals > 1 > balance Sheet > long Term Debt
5519301
Annuals > 1 > balance Sheet > total Liabilities
14459513
Annuals > 1 > balance Sheet > equity
17382857
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
1567575
Annuals > 1 > cash Flow > depreciation
4286904
Annuals > 1 > cash Flow > change In Working Capital
-743571
Annuals > 1 > cash Flow > cash From Operations
3063461
Annuals > 1 > cash Flow > capital Expenditures
1783212
Annuals > 1 > cash Flow > cash From Investing
-1998538
Annuals > 1 > cash Flow > cash From Financing
-1686708
Annuals > 1 > cash Flow > net Change In Cash
-621785
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
0.17367216120259807
Annuals > 1 > ratios > PB
1.4019764760188733
Annuals > 1 > ratios > ROE
9.017936464644448
Annuals > 1 > ratios > ROA
4.922921880500729
Annuals > 1 > ratios > FCF
1280249
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.06386434220399471
Annuals > 1 > health Score
64
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
17053185
Annuals > 2 > income Statement > cost Of Revenue
18363294
Annuals > 2 > income Statement > gross Profit
-1310109
Annuals > 2 > income Statement > operating Expenses
11001858
Annuals > 2 > income Statement > operating Income
949835
Annuals > 2 > income Statement > interest Expense
122031
Annuals > 2 > income Statement > pretax Income
758938
Annuals > 2 > income Statement > net Income
777752
Annuals > 2 > income Statement > eps
0.08817700977591703
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
8820349
Annuals > 2 > income Statement > income Tax Expense
-2697725
Annuals > 2 > income Statement > EBITDA
536794
Annuals > 2 > income Statement > operating Margin
5.569839299814082
Annuals > 2 > income Statement > total Other Income Expense Net
-190897
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
4879634
Annuals > 2 > balance Sheet > short Term Investments
-36298
Annuals > 2 > balance Sheet > receivables
13587396
Annuals > 2 > balance Sheet > inventories
1185361
Annuals > 2 > balance Sheet > total Current Assets
19822748
Annuals > 2 > balance Sheet > property Plant Equipment
6666631
Annuals > 2 > balance Sheet > total Assets
32923442
Annuals > 2 > balance Sheet > payables
2615649
Annuals > 2 > balance Sheet > short Term Debt
7221
Annuals > 2 > balance Sheet > long Term Debt
9038743
Annuals > 2 > balance Sheet > total Liabilities
16757387
Annuals > 2 > balance Sheet > equity
16166055
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
777752
Annuals > 2 > cash Flow > depreciation
2735574
Annuals > 2 > cash Flow > change In Working Capital
-975031
Annuals > 2 > cash Flow > cash From Operations
2355315
Annuals > 2 > cash Flow > capital Expenditures
1916711
Annuals > 2 > cash Flow > cash From Investing
-1941378
Annuals > 2 > cash Flow > cash From Financing
-1141286
Annuals > 2 > cash Flow > net Change In Cash
-727349
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
0.08817700977591703
Annuals > 2 > ratios > PB
1.4731449509481442
Annuals > 2 > ratios > ROE
4.81101913855916
Annuals > 2 > ratios > ROA
2.3623046460330603
Annuals > 2 > ratios > FCF
438604
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
0.025719770236469024
Annuals > 2 > health Score
47
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
14018969
Annuals > 3 > income Statement > cost Of Revenue
17765334
Annuals > 3 > income Statement > gross Profit
-3746365
Annuals > 3 > income Statement > operating Expenses
848381
Annuals > 3 > income Statement > operating Income
-4594748
Annuals > 3 > income Statement > interest Expense
274717
Annuals > 3 > income Statement > pretax Income
-4076942
Annuals > 3 > income Statement > net Income
-322598
Annuals > 3 > income Statement > eps
-0.0365592438513283
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
8823979
Annuals > 3 > income Statement > income Tax Expense
-3754344
Annuals > 3 > income Statement > EBITDA
-1878031
Annuals > 3 > income Statement > operating Margin
-32.77522048875349
Annuals > 3 > income Statement > total Other Income Expense Net
517806
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
5605051
Annuals > 3 > balance Sheet > short Term Investments
-36301
Annuals > 3 > balance Sheet > receivables
6358509
Annuals > 3 > balance Sheet > inventories
1031677
Annuals > 3 > balance Sheet > total Current Assets
19328779
Annuals > 3 > balance Sheet > property Plant Equipment
7168580
Annuals > 3 > balance Sheet > total Assets
32496985
Annuals > 3 > balance Sheet > payables
2216304
Annuals > 3 > balance Sheet > short Term Debt
5289
Annuals > 3 > balance Sheet > long Term Debt
8994812
Annuals > 3 > balance Sheet > total Liabilities
17939974
Annuals > 3 > balance Sheet > equity
14719758
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-322598
Annuals > 3 > cash Flow > depreciation
1924196
Annuals > 3 > cash Flow > change In Working Capital
-1986040
Annuals > 3 > cash Flow > cash From Operations
-561344
Annuals > 3 > cash Flow > capital Expenditures
2275639
Annuals > 3 > cash Flow > cash From Investing
-2263005
Annuals > 3 > cash Flow > cash From Financing
5714702
Annuals > 3 > cash Flow > net Change In Cash
2884874
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.0365592438513283
Annuals > 3 > ratios > PB
1.6185553661955583
Annuals > 3 > ratios > ROE
-2.1915985303562735
Annuals > 3 > ratios > ROA
-0.9927013229073405
Annuals > 3 > ratios > FCF
-2836983
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-0.20236744941799928
Annuals > 3 > health Score
25
Valuation > metrics > PE
14.7222
Valuation > metrics > PB
1.392374950401365
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
0.7775913189922655
Profitability > metrics > ROA
0.8362372598083905
Profitability > metrics > Net Margin
0.014891179839633447
Profitability > final Score
6
Profitability > verdict
Weak
Risk > metrics > Debt Equity
1.1111142649779993
Risk > metrics > Interest Coverage
1.7532467532467533
Risk > final Score
37
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.731915729645294
Liquidity > metrics > Quick Ratio
4.345790978860466
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
46
Prev Profitabilities > 1
30
Prev Profitabilities > 2
23
Prev Risks > 0
-61
Prev Risks > 1
-2
Prev Risks > 2
-107
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:08:49.808Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-24
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-29
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-10-17
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
EUR
Earnings History > 2 > eps Actual
0.02
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.02
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-07-18
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0.04
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0.04
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-06-30
Earnings History > 4 > report Date
2021-09-27
Earnings History > 4 > date
2021-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
-0.08
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.08
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2021-03-31
Earnings History > 5 > report Date
2021-06-23
Earnings History > 5 > date
2021-03-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
0.04
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.04
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-06-30
Earnings History > 6 > report Date
2020-09-17
Earnings History > 6 > date
2020-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
-0.17
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.17
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-03-31
Earnings History > 7 > report Date
2020-05-14
Earnings History > 7 > date
2020-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.18
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.18
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2019-09-30
Earnings History > 8 > report Date
2019-10-10
Earnings History > 8 > date
2019-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.18
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.18
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-03-31
Earnings History > 9 > report Date
2019-06-10
Earnings History > 9 > date
2019-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0.04
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2018-06-30
Earnings History > 10 > report Date
2018-09-21
Earnings History > 10 > date
2018-06-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
0.06
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.06
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2018-03-31
Earnings History > 11 > report Date
2018-05-09
Earnings History > 11 > date
2018-03-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
0.06
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.06
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2017-06-30
Earnings History > 12 > report Date
2017-09-14
Earnings History > 12 > date
2017-06-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0.27
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.27
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2017-03-31
Earnings History > 13 > report Date
2017-05-09
Earnings History > 13 > date
2017-03-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
0.07
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.07
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2016-06-30
Earnings History > 14 > report Date
2016-09-12
Earnings History > 14 > date
2016-06-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
0.03
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.03
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2016-03-31
Earnings History > 15 > report Date
2016-06-13
Earnings History > 15 > date
2016-03-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2014-12-31
Earnings History > 16 > report Date
2015-03-30
Earnings History > 16 > date
2014-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
0
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2014-06-30
Earnings History > 17 > report Date
2014-09-29
Earnings History > 17 > date
2014-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
0
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2013-12-31
Earnings History > 18 > report Date
2014-03-31
Earnings History > 18 > date
2013-12-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2013-06-30
Earnings History > 19 > report Date
2013-09-30
Earnings History > 19 > date
2013-06-30
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
0
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.
Stock Price
€0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AAlgen Biotechnologies Announces Multi-Target Partnership with AstraZeneca PharmExec.com
Read more →AstraZeneca signs $555 million gene-editing deal with Algen - report Investing.com
Read more →Showing 2 of 4
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Genoway
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.